Marketing-authorisation holder · Singapore
Taevas Life Sciences Pte Ltd
5 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
5 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BIOCON SITAGLIPTIN TABLETS USP 100mg100.000mg · Tablet, film coated | Sitagliptin | Singapore | Authorised | 2025 |
| BIOCON SITAGLIPTIN TABLETS USP 25mg25.000mg · Tablet, film coated | Sitagliptin | Singapore | Authorised | 2025 |
| BIOCON SITAGLIPTIN TABLETS USP 50mg50.000mg · Tablet, film coated | Sitagliptin | Singapore | Authorised | 2025 |
| DAPTOMYCIN BIOCON POWDER FOR SOLUTION FOR INJECTION/INFUSION 500MG/Vial500 mg/vial · Injection, powder, lyophilized, for solution | Daptomycin | Singapore | Authorised | 2025 |
| NALDEBAIN® EXTENDED RELEASE INJECTION 75MG/ML75mg/ ml · Injection, solution | Dinalbuphine sebacate | Singapore | Authorised | 2020 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|